Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
RHEUMATOID ARTHRITIS (RA) Gergely Péter dr Definition: Chronic destructive diseases characterized by joint inflammation with pain and swelling. In a considerable proportion of patients, the arthritis is progressive, resulting in joint destruction and ultimately incapacitation and increased mortality. Relatively common, prevalence: 0.3-1.5 %, the male:female ratio cca. 1:3. Typical case: woman aged 30-40 years with polyarthritis and early joint deformities. Endogenous factors MHC genes, hormon milieu) Exogenous factors cross-reacting antigenes, bacteria, viruses Synovial vasculitis Adhesion molecule expression cellular infiltration Macrophages, T cells, B cells, granulocytes Cytokines (TNF-a, IL-1, IL-6), RF, free-radicals, enzymes Synovial proliferation, angiogenesis, chondrocyte-, osteoclastactivation Pannus, cartilage destruction, bone resorption Pathogenesis of RA Cytokine Cytokinek interakciói interactions Classification criteria of RA (ARA, 1987) 1. Morning stiffness – for at least 1 hr and present for at least 6 weeks 2. Swelling of 3 or more joints for at least 6 weeks 3. Swelling of wrist, metacarpophalangeal (MCP) or proximal interphalangeal (PIP) joints for at least 6 weeks 4. Symmetric joint swelling 5. Typical radiologic changes in hands (erosions or unequivocal bony decalcification) 6. Rheumatoid nodules 7. Serum rheumatoid factor (RF) positivity Diagnosis is made by the presence of 4 or more criteria Differential diagnosis of polyarthritis RA should be differentiated from: - Other autoimmune diseases (SLE, primary Sjögren’s syndrome, MCTD, PM/DM, PSS, PAN, gian cell vasculitis, polymyalgia rheumatica, adult onset Still’s disease) - Viral diseases (parvovirus B19 infection, rubella, hepatitis B & C infection) - Bacterial infections (tbc, rheumatic fever, Jaccoud’s arthritis, septic endocarditis, mycoplasma arthritis) - Seronegative spondylarthritides (erosive psoriatic arthitis, reactive arthritis, enteropathic arthritis) - Paraneoplastic arthritis - Other diseases (e.g. hyperthrophic osteoarthropathy, erythema nodosum, agammaglobulinemia, acromegaly, diabetes mellitus) - Other rheumatic diseases (chronic gout, inflamed erosive osteoarthritis) Signs of early RA (=undifferentiated arthritis) In the early stage (within the first 3-6 months) (ARA) classification criteria cannot be used. The patient should be referred to a rheumatologist, if • • • the patient has 3 or more swollen joints the metacarpophalangeal (MCP) and/or metatarsophalangeal (MTP) joints are involved; the squeeze test is positive morning stiffness is 30 min or more. Squeeze test Joint involvement in RA The most specific sign of RA is arthritis. It is progressive and deforming in the majority (2/3) of cases (= erosive polyarthritis) RA early stage Early assymmetric RA PIP joint involvement in RA RA: swan neck deformity RA: ulnar deviation Ulnar deviation in RA with severe atrophy of interosseal muscles RA: Boutonnière deformity RA: arthritis mutilans Involvement of joints of feet in RA Severe destruction of ankles in RA Periarticular osteoporosis (decalcification) Erosions and sclerosis (in late stage) Erosion in RA Early erosions (MRI) Scintigraphy of the hands Baker’s cyst Bursitis in the shoulder Bursitis and rheumatoid nodule Rheumatoid nodules Atlantoaxial subluxation RA – end stage Extraarticular manifestations of RA • rheumatoid nodules • • • • • pleuritis/pericarditis fibrotizing alveolitis Felty’s syndrome vasculitis amyloidosis – subcutaneous - in internal organs (lung, aortic valve) Systemic manifestations of RA: pulmonary fibrosis Interstitial pneumonitis in RA Systemic manifestations of RA: Caplan’s syndrome Rheumatoid nodules in the lungs Episcleritis in RA Scleritis in RA Scleromalacia perforans Vasculitis in RA Vasculitis in RA Leg ulcers in Felty’s syndrome Large granular lymphocytes in Felty’s syndrome Disease modifying antirheumatic drugs (DMARD): Drug gold (i.m.) Adverse effects Dose dermatitis, stomatitis, 25-50 mg /2-4 proteinuria, enterocolitis, weeks thrombocytopenia gold (p.o.) less frequently used, brecause of lower tolerability chloroquine (hydroxy- retinopathia, pigment250 mg/day chloroquine) anomalies Regular ophthalmology check is required d-penicillamine proteinuria, myasthenia, 125-750 mg/day stomatitis Owing to low tolerability it is not used any more azathioprine hepatitis, bone marrow depression 50-150 mg/day Scarcely given in RA methotrexate hepatotoxicity, pulmonary fibrosis, 7,5-25 (MTX) bone marrow depression mg/week most frequently used therapy sulfasalazine cyclosporine A leflunomide TNF-a blockers: (etanercept, infliximab, and abatacept) nausea, vomiting 1,5-2 g/day diarrhea, bone marrow depression nephrotoxicity, tremor 1,5-4 mg/kg/day creatinine and blood pressure should be checked regularly hepatotoxicity, GI 10-20 mg/day complaints local reaction, autoimmune disease (SLE, SM) infection (tbc) etanercept: 25 mg 2x weekly s.c. infliximab: 3 mg/kg every 8 week i.v. Other: anakinra (IL-1 blocker) rituximab (anti-CD20 antibody) abatacept (T cell activation blocker antibody) Diseases related to RA: 1) Juvenile forms (= juvenile RA, juvenile idiopathic arthritis (JIA) Subgroups: a) systemic (Still’s disease) b) pauciarticular (<4 joints) c) polyarticular (similar to adult RA) 2) Seronegative (RF negative) forms (seronegative spondarthropathies = SNSA) a) Ankylosing spondylarthritis (Mo Bechterew) b) Psoriatic arthritis c) Reiter’s disease - postinfectious arthritis d) Enteropathic arthritis Classification criteria of JIA (ARA, 1982) 1. Persistent arthritis of at least 6 weeks duration in one or more joints 2. Exclusion of other causes of arthritis (in particular): a. other systemic autoimmune diseses (SLE, rheumatic fevers, vasculitis, PSS, SS, MCTD, Behçet’s syndrome, PM/DM, SPA, Reiter’s syndroma, psoriatic arthritis) b. Infectious arthritis c. Inflammatory bowel diseases d. Neoplasms (e.g. leukaemia) e. Nonrhematic conditions f. Hematologic diseases g. Psychogenic arthralgia h. Other (sarcoidosis, hyperthrophic osteoarthropathy, villonodular synovitis, chronic aktive hepatitis, familial Mediterranean fever) Child with advanced polyarticular JIA Micrognathia in JIA Typical skin rash in Still’s disease Inflamed joints with diffuse edema in SNSA (‘sausage-like’ fingers) Involvement of DIP joint in SNSA Asymmetric (MTP) arthritis in SNSA Skin and nails in psoriasis Exanthema in the rare adult onset Still’s disease